XORTX Therapeutics Inc. (XRTX) Net Cash Flow (2022)
XORTX Therapeutics (XRTX) posted Net Cash Flow of -$1.64 million for the year ended Dec 31, 2025, compared with -$938,063 a year earlier.
Powered by 
Analysis
XORTX Therapeutics Inc. (XRTX) Net Cash Flow (2022) Analysis & Trends
Since the year ended Dec 31, 2019, XORTX Therapeutics has reported Net Cash Flow for 7 years.
- Annual Net Cash Flow has run from a low of -$6.99 million in the year ended Dec 31, 2023 to a high of $24.38 million in the year ended Dec 31, 2021 over five years.
- Business Quant data shows XRTX's Net Cash Flow at -$938,063 in the year ended Dec 31, 2024, -$6.99 million in the year ended Dec 31, 2023, -$4.31 million in the year ended Dec 31, 2022 and $24.38 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
API Access
XORTX Therapeutics Inc. Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();